Virtual screening and cellular validation of dolutegravir as a BRD9 inhibitor for attenuating pyroptosis in peritoneal mesothelial cells. Gai J, Xing X, Gong C, Teng Y, et al. Ren Fail 2026;48:2644768.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gai J, Xing X, Gong C, Teng Y, et al. Virtual screening and cellular validation of dolutegravir as a BRD9 inhibitor for attenuating pyroptosis in peritoneal mesothelial cells. Ren Fail 2026;48:2644768.
PMID: 41943612